Search Results Search Sort by RelevanceMost Recent Case and Commentary Oct 2021 Holding Curative and Palliative Intentions Antoinette Esce, MD and Susan McCammon, MD, MFA Differentiating between best palliative care options and the curative and palliative potential of surgery is key to developing dual intentional clarity. AMA J Ethics. 2021;23(10):E766-771. doi: 10.1001/amajethics.2021.766. Case and Commentary Oct 2021 How to Support Patients Near the End of Life Whose Pain Is Best Treated With Surgery? Elle L. Kalbfell, MD and Margaret L. Schwarze, MD, MPP When surgical intervention is most appropriate, success should be defined by how well a surgical intervention aligns with a patient’s goals. AMA J Ethics. 2021;23(10):E772-777. doi: 10.1001/amajethics.2021.772. Case and Commentary Oct 2021 When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative? Michael J. Young, MD, MPhil, Robert W. Regenhardt, MD, PhD, Leonard L. Sokol, MD, and Thabele M. Leslie-Mazwi, MD For some patients whose survival is extended by disease-modifying interventions, little guidance about clinical and ethical complexities exist. AMA J Ethics. 2021;23(10):E783-793. doi: 10.1001/amajethics.2021.783. Case and Commentary Nov 2020 Should a Good Risk Manager Worry About Cost and Price Transparency in Health Care? Josh Charles Hyatt, DHSc, MHL, MBE(c) and Stephen L. Newman, MD, MBA Once focused on hospital liability, risk managers now navigate a broader set of enterprise risk management responsibilities. AMA J Ethics. 2020;22(11):E924-932. doi: 10.1001/amajethics.2020.924. Case and Commentary Oct 2019 How Should a Physician Respond to a Patient’s Pain When New Opioid Prescribing Laws Limit Shared Decision Making? Alexander J. Hjelmaas, MD and Christian J. Vercler, MD, MA Regulations’ negative influence on patient-physician relationships can be mitigated by innovation in decision science. AMA J Ethics. 2019;21(10):E838-843. doi: 10.1001/amajethics.2019.838. Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021. Case and Commentary Jun 2018 Is It Ethical to Treat Pain Differently in Children and Adults with Burns? Sharmila Dissanaike, MD Pain management of adult and pediatric burn patients should be individualized and include nonpharmacological treatment. AMA J Ethics. 2018;20(6):531-536. doi: 10.1001/journalofethics.2018.20.6.cscm1-1806. Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566. Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Case and Commentary Oct 2021 Holding Curative and Palliative Intentions Antoinette Esce, MD and Susan McCammon, MD, MFA Differentiating between best palliative care options and the curative and palliative potential of surgery is key to developing dual intentional clarity. AMA J Ethics. 2021;23(10):E766-771. doi: 10.1001/amajethics.2021.766.
Case and Commentary Oct 2021 How to Support Patients Near the End of Life Whose Pain Is Best Treated With Surgery? Elle L. Kalbfell, MD and Margaret L. Schwarze, MD, MPP When surgical intervention is most appropriate, success should be defined by how well a surgical intervention aligns with a patient’s goals. AMA J Ethics. 2021;23(10):E772-777. doi: 10.1001/amajethics.2021.772.
Case and Commentary Oct 2021 When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative? Michael J. Young, MD, MPhil, Robert W. Regenhardt, MD, PhD, Leonard L. Sokol, MD, and Thabele M. Leslie-Mazwi, MD For some patients whose survival is extended by disease-modifying interventions, little guidance about clinical and ethical complexities exist. AMA J Ethics. 2021;23(10):E783-793. doi: 10.1001/amajethics.2021.783.
Case and Commentary Nov 2020 Should a Good Risk Manager Worry About Cost and Price Transparency in Health Care? Josh Charles Hyatt, DHSc, MHL, MBE(c) and Stephen L. Newman, MD, MBA Once focused on hospital liability, risk managers now navigate a broader set of enterprise risk management responsibilities. AMA J Ethics. 2020;22(11):E924-932. doi: 10.1001/amajethics.2020.924.
Case and Commentary Oct 2019 How Should a Physician Respond to a Patient’s Pain When New Opioid Prescribing Laws Limit Shared Decision Making? Alexander J. Hjelmaas, MD and Christian J. Vercler, MD, MA Regulations’ negative influence on patient-physician relationships can be mitigated by innovation in decision science. AMA J Ethics. 2019;21(10):E838-843. doi: 10.1001/amajethics.2019.838.
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021.
Case and Commentary Jun 2018 Is It Ethical to Treat Pain Differently in Children and Adults with Burns? Sharmila Dissanaike, MD Pain management of adult and pediatric burn patients should be individualized and include nonpharmacological treatment. AMA J Ethics. 2018;20(6):531-536. doi: 10.1001/journalofethics.2018.20.6.cscm1-1806.
Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.